Series A - Neurofenix

Series A - Neurofenix

Investment Firm

Overview

Neurofenix is aiming to make rehabilitation more autonomous, enjoyable and accessible to stroke victims.

Announced Date

Aug 29, 2022

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

AlbionVC

AlbionVC

AlbionVC is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorInHealth Ventures
Participant InvestorHTH
Participant InvestorAlbionVC

Round Details and Background

Neurofenix raised $6915832 on 2022-08-29 in Series A

Neurofenix is aiming to make rehabilitation more autonomous, enjoyable and accessible to stroke victims.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 04, 2017
Grant - Neurofenix
-undefined
Feb 15, 2020
Seed Round - Neurofenix
2-undefined
Aug 29, 2022
Series A - Neurofenix
3-6.9M
Sep 08, 2016
Seed Round - Neurofenix
1-13.3K

Recent Activity

There is no recent news or activity for this profile.